ASHP Guidelines on Preventing Diversion of Controlled Substances

Clark, John PharmD, MS, BCPS, FASHP
Fera, Toni BS Pharm, PharmD
Fortier, Christopher PharmD, FASHP
Gullickson, Kristine PharmD, MBA, FASHP, FMSHP
Hays, Amanda PharmD, MHA, BCPS, CPHQ, DPLA, FASHP
Murdaugh, Lee BS Pharm, PhD
Ogden, Ricky Jr PharmD, MBA, BCPS, FACHE
O’Neal, Brian PharmD, MS, FASHP
Rush, Jordan PharmD, MS
Vest, Tyler PharmD, MS, BCPS, BCSCP

University of Michigan Health, Ann Arbor, MI, and University of Michigan College of Pharmacy, Ann Arbor, MI, USA
Independent Healthcare Consultant, Pittsburgh, PA, USA
Massachusetts General Hospital, Boston, MA, USA
Allina Health Abbott Northwestern Hospital, Minneapolis, MN, USA
Becton, Dickinson and Company, San Diego, CA, USA
Cardinal Health, Dublin, OH, USA
Children’s Mercy Kansas City, Kansas City, MO, USA
Children’s Mercy Kansas City, Kansas City, MO, USA
UNC Health, Chapel Hill, NC, USA
Duke University Hospital, Durham, NC, and University of North Carolina at Chapel Hill Eshelman School of Pharmacy, Chapel Hill, NC, USA

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/pages/standard-publication-reuse-rights)

American Journal of Health-System Pharmacy 79(24):p 2279-2306, December 15, 2022. | DOI: 10.1093/ajhp/zxac246